Citations (31)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Heta Shah, Manish Patel & Neeta Shrivastava. (2017) Gene expression study of phase I and II metabolizing enzymes in RPTEC/TERT1 cell line: application in in vitro nephrotoxicity prediction. Xenobiotica 47:10, pages 837-843.
Read now
Read now
Leslie C Bell & Jianling Wang. (2012) Probe ADME and Test Hypotheses: a PATH beyond clearance in vitro–in vivo correlations in early drug discovery. Expert Opinion on Drug Metabolism & Toxicology 8:9, pages 1131-1155.
Read now
Read now
Karen Rowland Yeo, Mohsen Aarabi, Masoud Jamei & Amin Rostami-Hodjegan. (2011) Modeling and predicting drug pharmacokinetics in patients with renal impairment. Expert Review of Clinical Pharmacology 4:2, pages 261-274.
Read now
Read now
Hesham M. Korashy & Ayman O. S. El-Kadi. (2006) The Role of Aryl Hydrocarbon Receptor in the Pathogenesis of Cardiovascular Diseases. Drug Metabolism Reviews 38:3, pages 411-450.
Read now
Read now
Articles from other publishers (27)
Lukasz Dobrek. (2023) A Synopsis of Current Theories on Drug-Induced Nephrotoxicity. Life 13:2, pages 325.
Crossref
Crossref
UMESH M. HANUMEGOWDA & CARL DAVIS. 2022. Drug Metabolism Handbook. Drug Metabolism Handbook
605
676
.
Mo'tasem M. Alsmadi, Nour M AL‐Daoud, Mays M. Jaradat, Saja B. Alzughoul, Amani D. Abu Kwiak, Salam S. Abu Laila, Ayat J. Abu Shameh, Mohammad K. Alhazabreh, Sana'a A. Jaber & Hala T. Abu Kassab. (2021) Physiologically‐based pharmacokinetic model for alectinib, ruxolitinib, and panobinostat in the presence of cancer, renal impairment, and hepatic impairment. Biopharmaceutics & Drug Disposition 42:6, pages 263-284.
Crossref
Crossref
Yvonne S. Lin, Kenneth E. Thummel, Brice D. Thompson, Rheem A. Totah & Christi W. Cho. 2021. Enzyme Kinetics in Drug Metabolism. Enzyme Kinetics in Drug Metabolism
481
550
.
Giovanni Galati, Antonio Fabio Massimo Vainieri, Claudia Angela Maria Fulgenzi, Stefano Di Donato, Marianna Silletta, Paolo Gallo, Angelo Onorato, Umberto Vespasiani-Gentilucci & Antonio Picardi. (2020) Current Treatment Options for HCC: From Pharmacokinetics to Efficacy and Adverse Events in Liver Cirrhosis. Current Drug Metabolism 21:11, pages 866-884.
Crossref
Crossref
Santosh Kumar Puttrevu, Sumit Arora, Sebastian Polak & Nikunj Kumar Patel. (2020) Physiologically Based Pharmacokinetic Modeling of Transdermal Selegiline and Its Metabolites for the Evaluation of Disposition Differences between Healthy and Special Populations. Pharmaceutics 12:10, pages 942.
Crossref
Crossref
J.C. Coons & P. Empey. 2017. Drug Metabolism in Diseases. Drug Metabolism in Diseases
139
156
.
Kenneth E. Thummel & Yvonne S. Lin. 2014. Enzyme Kinetics in Drug Metabolism. Enzyme Kinetics in Drug Metabolism
363
415
.
Shivaani Kummar, S. Percy Ivy & Pamela Jo Harris. 2014. Handbook of Anticancer Pharmacokinetics and Pharmacodynamics. Handbook of Anticancer Pharmacokinetics and Pharmacodynamics
673
688
.
Alexander V. LyubimovShalu Jhajra, Ninad Ramesh Varkhede, Deepak Suresh Ahire, Bukke Vidyasagar Naik, Bhagwat Prasad, Jyoti Paliwal & Saranjit Singh. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions
1
99
.
Masoud Jamei, Karen R. Yeo, Trevor N. Johnson, Cyrus Ghobadi, Manoranjenni Chetty, Khaled Abduljalil, Gaohua Lu, Farzaneh Salem, Adam Darwich & Amin Rostami-Hodjegan. 2012. Biosimulation in Biomedical Research, Health Care and Drug Development. Biosimulation in Biomedical Research, Health Care and Drug Development
361
386
.
Olivier Mimoz, Stéphane Chauvet, Nicolas Grégoire, Sandrine Marchand, Marie-Emmanuelle Le Guern, Ashraf Saleh, William Couet, Bertrand Debaene & René H. Levy. (2010) Nefopam Pharmacokinetics in Patients with End-Stage Renal Disease. Anesthesia & Analgesia 111:5, pages 1146-1153.
Crossref
Crossref
Carl D. Davis & Umesh M. Hanumegowda. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia
1
68
.
Hyung-Sub KIM, Noriaki SAKAI, Konomu SAITO, Shoichi FUJITA & Mayumi ISHIZUKA. (2010) Diazepam Metabolism in the Kidneys of Male and Female Rats of Various Strains. Journal of Veterinary Medical Science 72:1, pages 7-11.
Crossref
Crossref
Edward A. Lock. 2009. General, Applied and Systems Toxicology. General, Applied and Systems Toxicology.
Masato Chiba, Yasuyuki Ishii & Yuichi Sugiyama. (2009) Prediction of Hepatic Clearance in Human From In Vitro Data for Successful Drug Development. The AAPS Journal 11:2.
Crossref
Crossref
Carl D. Davis & Umesh M. Hanumegowda. 2009. Drug Metabolism Handbook. Drug Metabolism Handbook
559
628
.
Wael Lasheen. 2009. Palliative Medicine. Palliative Medicine
700
706
.
Ihab M. Wahba, Ali J. Olyaei, David Rozansky & William M. Bennett. 2009. Pediatric Nephrology. Pediatric Nephrology
1693
1711
.
Rainer Preiss & Jens Teichert. 2008. Lipoic Acid. Lipoic Acid.
Ivan Bièche, Cèline Narjoz, Tarik Asselah, Sophie Vacher, Patrick Marcellin, Rosette Lidereau, Philippe Beaune & Isabelle de Waziers. (2007) Reverse transcriptase-PCR quantification of mRNA levels from cytochrome (CYP)1, CYP2 and CYP3 families in 22 different human tissues. Pharmacogenetics and Genomics 17:9, pages 731-742.
Crossref
Crossref
Reem H. Elbekai & Ayman O.S. El-Kadi. (2006) Cytochrome P450 enzymes: Central players in cardiovascular health and disease. Pharmacology & Therapeutics 112:2, pages 564-587.
Crossref
Crossref
Yasuhiro Masubuchi, Mamiko Kawasaki & Toshiharu Horie. (2006) Down-regulation of hepatic cytochrome P450 enzymes associated with cisplatin-induced acute renal failure in male rats. Archives of Toxicology 80:6, pages 347-353.
Crossref
Crossref
Henry J. Mann. (2006) Drug-Associated Disease: Cytochrome P450 Interactions. Critical Care Clinics 22:2, pages 329-345.
Crossref
Crossref
Masuhiro Nishimura & Shinsaku Naito. (2006) Tissue-Specific mRNA Expression Profiles of Human Phase I Metabolizing Enzymes Except for Cytochrome P450 and Phase II Metabolizing Enzymes. Drug Metabolism and Pharmacokinetics 21:5, pages 357-374.
Crossref
Crossref
Sylvia Notenboom, David S. Miller, Leon H. Kuik, Paul Smits, Frans G. M. Russel & Rosalinde Masereeuw. (2005) Short-Term Exposure of Renal Proximal Tubules to Gentamicin Increases Long-Term Multidrug Resistance Protein 2 (Abcc2) Transport Function and Reduces Nephrotoxicant Sensitivity. Journal of Pharmacology and Experimental Therapeutics 315:2, pages 912-920.
Crossref
Crossref
Jens Teichert, Tina Tuemmers, Harald Achenbach, Christa Preiss, Robert Hermann, Peter Ruus & Rainer Preiss. (2005) Pharmacokinetics of Alpha-Lipoic Acid in Subjects With Severe Kidney Damage and End-Stage Renal Disease. The Journal of Clinical Pharmacology 45:3, pages 313-328.
Crossref
Crossref